Ambolt Health ApS: Financial statements 2020
CVR: 39662442
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Ambolt Health ApS (CVR 39662442) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -11,635 and a net result of DKK -14,282 compared with DKK -1,652 the year before. Equity in the 2020 report amounted to DKK -47,854.
- Gross Profit
- DKK -11,635
- Profit/Loss
- DKK -14,282
- Equity
- DKK -47,854
- Total Assets
- DKK 875,047
- Employees
- 0
Official annual report
How creditworthy is Ambolt Health ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Ambolt Health ApS has published its annual report for 2019. Gross profit came to DKK -437, and the net result was DKK -1,652.
As of August 12, 2020, Steen Palle Petersen is registered as director of Ambolt Health ApS.
As of August 12, 2020, Kent Munthe Caspersen has stepped down as director of Ambolt Health ApS.
As of August 12, 2020, Mathias Meldgaard Andersen has stepped down as director of Ambolt Health ApS.
About Ambolt Health ApS
Ambolt Health ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2018. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named Intmed Danmark ApS and Intmed Danmark IVS. The management consists of Andreas Berre Eriksen and Steen Palle Petersen. The company is owned by Ambolt Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 5,309,279 and a net result of DKK 1,900,215 compared with DKK 1,733,386 the year before. Equity in the 2025 report amounted to DKK 2,298,782.